The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $273,933.00 firm-fixed-price definitive contract to Verinetics, Inc. (doing business as Certirx Corp), a for-profit small business organization, for work to be performed at Research Triangle Park, NC. The contract was set aside for small businesses and has a completion date of June 30, 2020. No additional details about the specific products or services to be provided under this...
The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) awarded a $1,494,724.00 Small Business Technology Transfer (STTR) Phase II contract to B & W TEK Inc., a for-profit manufacturer. The contract is for the development and testing of an advanced system for safely detecting, neutralizing, and disposing of controlled substance pharmaceutical waste. This is a follow-on effort to a previous $224,656.02 SBIR Phase I...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Phase I contract to Portable Diagnostic Systems Inc. in Robbinsville, New Jersey. The contract, with a potential value of $400,000.00, is for the development of an ultraportable lab-on-a-chip biosensor system for rapid postmortem toxicology. The period of performance is September 27, 2023 to September 26, 2024, and the...
This is a $300,000.00 Firm Fixed Price Definitive Contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Base Pair Biotechnologies Inc., a small business concern, to develop aptasensors for measuring long-term adherence to tenofovir-based and long-acting HIV treatment regimens. The contract was awarded under the Small Business Innovation Research (SBIR) program, which is designed to stimulate technological...
The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $382,010.00 Firm Fixed Price Delivery Order contract to Vitae Enim Vitae Scientific, Inc. (VEV Scientific) on September 27, 2024. The contract is for dosage form reprocessing and stability studies of the FX-5A injection drug product under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Chemistry, Manufacturing and Controls (CMC) and related services to support drug product development. The contract...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $2,451,736.00 cost-plus-fixed-fee contract to Medispin Inc., a small business, for R&D in physical science. The 3-year contract (ultimate completion date of Nov 30, 2009) was awarded on Sep 22, 2006 under a total small business set-aside. The contract is for research and experimental development activities related to the agency's mission.</p>
This federal contract award is a delivery order under a larger contract vehicle, with Research Triangle Institute (RTI) International as the prime contractor. The contract is with the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The award, valued at $376,358.00, is for the synthesis and distribution of drugs of abuse and related compounds over a one-year period from June 16, 2024 to June 15, 2025, with a total period of...
<p>The U.S. Department of Health and Human Services (HHS) National Institute on Drug Abuse (NIDA) awarded a $749,913.00 Cost Plus Fixed Fee contract to Cyke Incorporated, a small business, for the development of an Autism Internet Resource for Physicians under the Small Business Innovation Research (SBIR) Program Phase II. The contract has a completion date of January 30, 2008.</p>
This federal contract award, with a ceiling value of $1,927,163.66, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The contract was awarded to SRI International, a non-profit research and development organization, and is part of NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract, which is a Delivery Order under the PTNP Indefinite Delivery Vehicle (IDV), is for IND-enabling studies....
This federal contract award, with an ID of HHSN271201500432P, was issued by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), to Cisbio US, Inc., a foreign-owned for-profit company. The $128,330.00 firm-fixed-price purchase order contract was set aside for a small business. It was awarded on July 21, 2015, with an ultimate completion date of August 21, 2015. Based on Cisbio US, Inc.'s past federal contract experience, the contract...